How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

56,236 results for

Radiation Therapy

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Clinical Appropriateness Guidelines: Radiation Oncology Brachytherapy, intensity modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT) and stereotactic radiosurgery (SRS) treatment guidelines

Clinical Appropriateness Guidelines: Radiation Oncology Brachytherapy, intensity modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT) and stereotactic radiosurgery (SRS) treatment guidelines Clinical Appropriateness Guidelines: Radiation Oncology Brachytherapy, intensity modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT) and stereotactic radiosurgery (SRS) treatment guidelines Effective Date: January 1, 2018 Proprietary Date of Origin: 05/14 (...) contained herein or not contained herein. Description and Application of the GuidelinesRadiation Oncology Image Guidance | Copyright © 2018. AIM Specialty Health. All Rights Reserved. 4 Modalities used in Image Guidance ? Ultrasound-based guidance ? Stereoscopic x-ray guidance ? CT based image guidance ? Real-time intrafraction guidance Radiation Oncology Considerations Image guidance, also known as image-guided radiation therapy (IGRT), refers to pre-treatment imaging used to verify correct patient

2018 AIM Specialty Health

2. Selective internal radiation therapy for unresectable primary intrahepatic cholangiocarcinoma

Selective internal radiation therapy for unresectable primary intrahepatic cholangiocarcinoma Selectiv Selective internal r e internal radiation ther adiation therap apy for y for unresectable primary intr unresectable primary intrahepatic ahepatic cholangiocarcinoma cholangiocarcinoma Interventional procedures guidance Published: 31 October 2018 nice.org.uk/guidance/ipg630 Y Y our responsibility our responsibility This guidance represents the view of NICE, arrived at after careful (...) IPG459. © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 1 of 51 1 Recommendations Recommendations 1.1 Current evidence on the safety of selective internal radiation therapy (SIRT) for unresectable primary intrahepatic cholangiocarcinoma shows that there are well-recognised, serious but rare safety concerns. Evidence on its efficacy is inadequate in quantity and quality. Therefore, this procedure should only be used

2018 National Institute for Health and Clinical Excellence - Interventional Procedures

3. Radiation therapy for early Dupuytren's disease

Radiation therapy for early Dupuytren's disease Radiation ther Radiation therap apy for early Dupuytren y for early Dupuytren's disease 's disease Interventional procedures guidance Published: 21 December 2016 nice.org.uk/guidance/ipg573 Y Y our responsibility our responsibility This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expected to take this guidance fully (...) . Nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties. Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. This guidance replaces IPG368. 1 1 Recommendations Recommendations 1.1 The evidence on radiation therapy for early Dupuytren's disease raises no major safety

2017 National Institute for Health and Clinical Excellence - Interventional Procedures

4. Radical Prostatectomy and Radiation Therapy for Prostate Cancer: Clinical Effectiveness and Guidelines

Radical Prostatectomy and Radiation Therapy for Prostate Cancer: Clinical Effectiveness and Guidelines Radical Prostatectomy and Radiation Therapy for Prostate Cancer: Clinical Effectiveness and Guidelines | CADTH.ca Find the information you need Radical Prostatectomy and Radiation Therapy for Prostate Cancer: Clinical Effectiveness and Guidelines Radical Prostatectomy and Radiation Therapy for Prostate Cancer: Clinical Effectiveness and Guidelines Last updated: September 5, 2019 Project Number (...) : RA1061-000 Product Line: Research Type: Devices and Systems Report Type: Reference List Result type: Report Question What is the clinical effectiveness of radical prostatectomy for early-stage or screen-detected prostate cancer? What is the clinical effectiveness of radiation therapy for early-stage or screen-detected prostate cancer? What are the evidence-based guidelines on the use of radical prostatectomy for prostate cancer? What are the evidence-based guidelines on the use of radiation therapy

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review

5. Magnetic Resonance Imaging Simulators for Simulation and Treatment for Patients Requiring Radiation Therapy: A Review of the Clinical Effectiveness, Cost-Effectiveness, and Guidelines

Magnetic Resonance Imaging Simulators for Simulation and Treatment for Patients Requiring Radiation Therapy: A Review of the Clinical Effectiveness, Cost-Effectiveness, and Guidelines Magnetic Resonance Imaging Simulators for Simulation and Treatment for Patients Requiring Radiation Therapy: A Review of the Clinical Effectiveness, Cost-Effectiveness, and Guidelines | CADTH.ca Find the information you need Magnetic Resonance Imaging Simulators for Simulation and Treatment for Patients Requiring (...) Radiation Therapy: A Review of the Clinical Effectiveness, Cost-Effectiveness, and Guidelines Magnetic Resonance Imaging Simulators for Simulation and Treatment for Patients Requiring Radiation Therapy: A Review of the Clinical Effectiveness, Cost-Effectiveness, and Guidelines Last updated: January 16, 2019 Project Number: RC1058-000 Product Line: Research Type: Devices and Systems Report Type: Summary with Critical Appraisal Result type: Report Question What is the clinical effectiveness of the use

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review

6. Odomzo (sonidegib) - To treat patients with locally advanced basal cell carcinoma that has recurred following surgery or radiation therapy, or who are not candidates for surgery or radiation therapy

Odomzo (sonidegib) - To treat patients with locally advanced basal cell carcinoma that has recurred following surgery or radiation therapy, or who are not candidates for surgery or radiation therapy Odomzo sonidegib Capsules U.S. Department of Health and Human Services Search FDA Submit search Odomzo sonidegib Capsules Odomzo, 200 mg Capsules Company: Norvartis Pharmaceuticals Corporation Application No.: 205266 Approval Date: 07/24/2015 Persons with disabilities having problems accessing

2015 FDA - Drug Approval Package

9. Benzydamine for the Treatment of Oropharyngeal Mucositis from Radiation Therapy: A Review of Clinical Effectiveness and Guidelines

Benzydamine for the Treatment of Oropharyngeal Mucositis from Radiation Therapy: A Review of Clinical Effectiveness and Guidelines Benzydamine for the Treatment of Oropharyngeal Mucositis from Radiation Therapy: A Review of Clinical Effectiveness and Guidelines | CADTH.ca Find the information you need Benzydamine for the Treatment of Oropharyngeal Mucositis from Radiation Therapy: A Review of Clinical Effectiveness and Guidelines Benzydamine for the Treatment of Oropharyngeal Mucositis from (...) Radiation Therapy: A Review of Clinical Effectiveness and Guidelines Last updated: September 27, 2018 Project Number: RC1021-000 Product Line: Research Type: Drug Report Type: Summary with Critical Appraisal Result type: Report Question What is the clinical effectiveness of benzydamine oral rinse ( 15%) for the symptomatic relief of oropharyngeal mucositis caused by radiation therapy? What are guidelines informing the use of benzydamine oral rinse ( 15%) for the symptomatic relief of oropharyngeal

2018 Canadian Agency for Drugs and Technologies in Health - Rapid Review

10. Review of Real-Time 3-Dimensional Image Guided Radiation Therapy on Standard-Equipped Cancer Radiation Therapy Systems: Are We at the Tipping Point for the Era of Real-Time Radiation Therapy? Full Text available with Trip Pro

Review of Real-Time 3-Dimensional Image Guided Radiation Therapy on Standard-Equipped Cancer Radiation Therapy Systems: Are We at the Tipping Point for the Era of Real-Time Radiation Therapy? To review real-time 3-dimensional (3D) image guided radiation therapy (IGRT) on standard-equipped cancer radiation therapy systems, focusing on clinically implemented solutions.Three groups in 3 continents have clinically implemented novel real-time 3D IGRT solutions on standard-equipped linear (...) coverage and variable normal tissue doses were found without real-time 3D IGRT. The geometric accuracy results with real-time 3D IGRT had a mean error of <0.5 mm and a standard deviation of <1.1 mm. Numerous additional articles exist that describe real-time 3D IGRT methods using standard-equipped radiation therapy systems that could also be clinically implemented.Multiple clinical implementations of real-time 3D IGRT on standard-equipped cancer radiation therapy systems have been demonstrated. Many

2018 Biology and Physics

11. ACR-ABS-ACNM-ASTRO-SIR-SNMMI Practice Parameters for Selective Internal Radiation Therapy (SIRT) or Radioembolization for Treatment of Liver Malignancies

ACR-ABS-ACNM-ASTRO-SIR-SNMMI Practice Parameters for Selective Internal Radiation Therapy (SIRT) or Radioembolization for Treatment of Liver Malignancies PRACTICE PARAMETER 1 SIRT or Radioembolization The American College of Radiology, with more than 30,000 members, is the principal organization of radiologists, radiation oncologists, and clinical medical physicists in the United States. The College is a nonprofit professional society whose primary purposes are to advance the science (...) radiology requires specific training, skills, and techniques, as described in each document. Reproduction or modification of the published practice parameter and technical standard by those entities not providing these services is not authorized. Revised 2019 (Resolution 21)* ACR–ABS–ACNM–ASTRO–SIR–SNMMI PRACTICE PARAMETER FOR SELECTIVE INTERNAL RADIATION THERAPY (SIRT) OR RADIOEMBOLIZATION FOR TREATMENT OF LIVER MALIGNANCIES PREAMBLE This document is an educational tool designed to assist practitioners

2019 Society of Interventional Radiology

12. Brachytherapy: A critical component of primary radiation therapy for cervical cancer

Brachytherapy: A critical component of primary radiation therapy for cervical cancer Brachytherapy: A critical component of primary radiation therapy for cervical cancer - Gynecologic Oncology Email/Username: Password: Remember me Search Terms Search within Search Volume 152, Issue 3, Pages 540–547 To read this article in full, please review your options for gaining access at the bottom of the page. Brachytherapy: A critical component of primary radiation therapy for cervical cancer From (...) ; To view the full text, please login as a subscribed user or . Click to view the full text on ScienceDirect. Figures Fig. 1 Adjusted overall survival by boost modality (brachytherapy vs. IMRT/SBRT) as corrected for age, Charlson/Deyo comorbidity score, stage, and chemotherapy utilization. (Reprinted from Gill BS, Lin JF, Krivak TC, et al. National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer: the impact of new technological advancements. Int J Radiat Oncol

2019 Society of Gynecologic Oncology

13. Radiation Therapy for Pancreatic Cancer

Radiation Therapy for Pancreatic Cancer Practical Radiation Oncology Email/Username: Password: Remember me Search Terms Search within Search Share this page: To read this article in full, please review your options for gaining access at the bottom of the page. Access this article on Visit ScienceDirect to see if you have access via your institution. Article Tools (100 minimum order) Article Related Video Article Related Audio Related Articles Searching for related articles.. Copyright © 2019

2019 American Society for Radiation Oncology

14. Radiation Therapy for the Whole-Breast (ASTRO)

Radiation Therapy for the Whole-Breast (ASTRO) Practical Radiation Oncology (2018) Radiation Therapy for the Whole Breast: An American Society for Radiation Oncology (ASTRO) Evidence-Based Guideline Benjamin D. Smith, MD, a* Jennifer R. Bellon, MD, b Rachel Blitzblau, MD, PhD, c Gary Freedman, MD, d Bruce Haffty, MD, e Carol Hahn, MD, f Francine Halberg, MD, g Karen Hoffman, MD, a Kathleen Horst, MD, h Jean M. Moran, PhD, i Caroline Patton, MA, j Jane Perlmutter, PhD, k Laura Warren, MD, b (...) in this guideline and that may, over time, be a basis for ASTRO to revisit and update the guideline. 3 ASTRO WHOLE BREAST IRRADIATION GUIDELINE Practical Radiation Oncology Introduction Breast cancer is the most common malignancy treated with radiation therapy (RT) in the United States, and whole breast irradiation (WBI) is the most common type of RT prescribed for breast cancer. 1 Historically, the standard of care for WBI in the United States has been conventional fractionation (CF), defined as daily doses

2019 American Society for Radiation Oncology

15. ASTRO Guideline on Palliative Radiation Therapy for Non-small Cell Lung Cancer (NSCLC) - Update Full Text available with Trip Pro

ASTRO Guideline on Palliative Radiation Therapy for Non-small Cell Lung Cancer (NSCLC) - Update Palliative thoracic radiation therapy for non-small cell lung cancer: 2018 Update of an American Society for Radiation Oncology (ASTRO) Evidence-Based Guideline - Practical Radiation Oncology Email/Username: Password: Remember me Search Terms Search within Search Share this page: Volume 8, Issue 4, Pages 245–250 Palliative thoracic radiation therapy for non-small cell lung cancer: 2018 Update (...) Accepted: February 19, 2018 ; Received: February 6, 2018 ; Abstract Purpose To revise the recommendation on the use of concurrent chemotherapy (CC) with palliative thoracic external beam radiation therapy (EBRT) made in the original 2011 American Society for Radiation Oncology guideline on palliative thoracic radiation for lung cancer. Methods and materials Based on a systematic PubMed search showing new evidence for this key question, the task force felt an update was merited. Guideline

2019 American Society for Radiation Oncology

16. Standardizing Normal Tissue Contouring for Radiation Therapy Treatment Planning

Standardizing Normal Tissue Contouring for Radiation Therapy Treatment Planning Special Article Standardizing Normal Tissue Contouring for Radiation Therapy Treatment Planning: An ASTRO Consensus Paper Jean L. Wright MD a , Sue S. Yom MD, PhD, MAS b , Musaddiq J. Awan MD c , Samantha Dawes CMD d, *, Benjamin Fischer-Valuck MD e , Randi Kudner MA d , Raymond Mailhot Vega MD, MPH f , George Rodrigues MD, PhD g a Johns Hopkins University, Baltimore, Maryland; b University of California, San (...) Francisco, California; c Medical College of Wisconsin, Milwaukee, Wisconsin; d American Society for Radiation Oncology, Arlington, Virginia; e Emory University, Atlanta, Georgia; f University of Florida, Jacksonville, Florida; g London Health Sciences Centre, London, ON, Canada Received 4 September 2018; revised 29 November 2018; accepted 8 December 2018 Abstract Purpose: Thecomprehensiveidenti?cationanddelineationoforgansatrisk(OARs)arevitaltothe quality of radiation therapy treatment planning

2019 American Society for Radiation Oncology

17. Re: Surrogate End Points for All-Cause Mortality in Men with Localized Unfavorable-Risk Prostate Cancer Treated with Radiation Therapy vs Radiation Therapy plus Androgen Deprivation Therapy: A Secondary Analysis of a Randomized Clinical Trial. (Abstract)

Re: Surrogate End Points for All-Cause Mortality in Men with Localized Unfavorable-Risk Prostate Cancer Treated with Radiation Therapy vs Radiation Therapy plus Androgen Deprivation Therapy: A Secondary Analysis of a Randomized Clinical Trial. 29310183 2019 01 21 2019 01 21 1527-3792 199 1 2018 01 The Journal of urology J. Urol. Re: Surrogate End Points for All-Cause Mortality in Men with Localized Unfavorable-Risk Prostate Cancer Treated with Radiation Therapy vs Radiation Therapy plus (...) Androgen Deprivation Therapy: A Secondary Analysis of a Randomized Clinical Trial. 28 S0022-5347(17)77695-1 10.1016/j.juro.2017.10.008 Taneja Samir S SS eng Journal Article Comment 2017 10 06 United States J Urol 0376374 0022-5347 0 Biomarkers AIM IM JAMA Oncol. 2017 May 1;3(5):652-658 28097317 Biomarkers Humans Male Prostatic Neoplasms 2018 1 10 6 0 2018 1 10 6 0 2019 1 22 6 0 ppublish 29310183 S0022-5347(17)77695-1 10.1016/j.juro.2017.10.008

2019 The Journal of urology Controlled trial quality: uncertain

18. Dental Management of Pediatric Patients Receiving Chemotherapy, Hematopoietic Cell Transplantation, and/or Radiation Therapy

Dental Management of Pediatric Patients Receiving Chemotherapy, Hematopoietic Cell Transplantation, and/or Radiation Therapy 392 RECOMMENDATIONS: BEST PRACTICES REFERENCE MANUAL V 40 / NO 6 18 / 19 Purpose The American Academy of Pediatric Dentistry (AAPD) recognizes that the pediatric dental professional plays an im- portant role in the diagnosis, prevention, stabilization, and treatment of oral and dental problems that can compromise the child’s quality of life before, during, and after (...) immuno- suppressive therapy which lowers the body’s normal immune response. This can be deliberate as in lowering the immune response to prevent the rejection of an organ or hematopoietic cell transplant* (HCT), or it can be incidental as in a side effect of chemotherapy, radiation therapy, or HCT conditioning. Dental intervention with certain modifications must be done promptly and efficiently, with attention to the patient’s medical history, treatment protocol, and health status. Immunosuppressive

2018 American Academy of Pediatric Dentistry

19. Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases. Full Text available with Trip Pro

Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases. Historically, whole brain radiation therapy (WBRT) has been the main treatment for brain metastases. Stereotactic radiosurgery (SRS) delivers high-dose focused radiation and is being increasingly utilized to treat brain metastases. The benefit of adding SRS to WBRT is unclear. This is an updated version of the original Cochrane Review published in Issue 9, 2012.To assess the efficacy (...) studies, 129 participants; moderate-quality evidence). Furthermore, we observed an improvement in performance status scores and decrease in steroid use in the WBRT plus SRS group (risk ratio (RR) 0.64 CI 0.42 to 0.97; 1 study, 118 participants; low-quality evidence). Unchanged or improved Karnofsky Performance Scale (KPS) at six months was seen in 43% of participants in the combined therapy group versus only 28% in the WBRT-alone group (RR 0.78 CI 0.61 to 1.00; P value = 0.05; 1 study, 118

2017 Cochrane

20. Radiation therapy with concurrent cisplatin versus radiation therapy with concurrent cetuximab in locally advanced HNSCC: a meta-analysis

Radiation therapy with concurrent cisplatin versus radiation therapy with concurrent cetuximab in locally advanced HNSCC: a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration (...) study 3. No metastases/ only primary tumor 4. No control group 5. Combination therapy or contamination 6. Not about analgesics used in the clinic Full text-screening: As above, with the addition of: 7. No relevant outcome measure reported ">Prioritise the exclusion criteria Example: Two reviewers will independently extract data from each article. We first try to extract numerical data from tables, text or figures. If these are not reported, we will extract data from graphs using digital ruler

2019 PROSPERO

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>